Volume 70, Issue 2, Pages e6 (April 2018)

Slides:



Advertisements
Similar presentations
Purusharth Rajyaguru, Meipei She, Roy Parker  Molecular Cell 
Advertisements

Volume 126, Issue 7, Pages (June 2004)
Shan Zhang, Chengchao Xu, Katherine E. Larrimore, Davis T.W. Ng  Cell 
Usa1 Functions as a Scaffold of the HRD-Ubiquitin Ligase
The UBA2 Domain Functions as an Intrinsic Stabilization Signal that Protects Rad23 from Proteasomal Degradation  Stijn Heessen, Maria G. Masucci, Nico.
Volume 123, Issue 5, Pages (December 2005)
Volume 8, Issue 6, Pages (December 2008)
Volume 22, Issue 5, Pages (May 2012)
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Monica C. Rodrigo-Brenni, Erik Gutierrez, Ramanujan S. Hegde 
Meghal Gandhi, Vérane Achard, Laurent Blanchoin, Bruce L. Goode 
Volume 47, Issue 1, Pages (July 2012)
Volume 15, Issue 22, Pages (November 2005)
Volume 42, Issue 6, Pages (June 2011)
Sichen Shao, Karina von der Malsburg, Ramanujan S. Hegde 
Volume 127, Issue 1, Pages (October 2006)
Stuart W. Hicks, Guillaume Charron, Howard C. Hang, Jorge E. Galán 
Christopher R Cowles, Greg Odorizzi, Gregory S Payne, Scott D Emr  Cell 
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
More Than One Glycan Is Needed for ER Glucosidase II to Allow Entry of Glycoproteins into the Calnexin/Calreticulin Cycle  Paola Deprez, Matthias Gautschi,
Volume 41, Issue 2, Pages (January 2011)
Distinct Autophagosomal-Lysosomal Fusion Mechanism Revealed by Thapsigargin- Induced Autophagy Arrest  Ian G. Ganley, Pui-Mun Wong, Noor Gammoh, Xuejun.
Folding of CFTR Is Predominantly Cotranslational
Class C Vps Protein Complex Regulates Vacuolar SNARE Pairing and Is Required for Vesicle Docking/Fusion  Trey K. Sato, Peter Rehling, Michael R. Peterson,
Transcription Factor MIZ-1 Is Regulated via Microtubule Association
A Branched Pathway Governing the Activation of a Developmental Transcription Factor by Regulated Intramembrane Proteolysis  Nathalie Campo, David Z. Rudner 
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 6, Issue 2, Pages (August 2007)
Positive or Negative Roles of Different Cyclin-Dependent Kinase Pho85-Cyclin Complexes Orchestrate Induction of Autophagy in Saccharomyces cerevisiae 
Volume 69, Issue 2, Pages e4 (January 2018)
Volume 14, Issue 1, Pages (January 2008)
Volume 48, Issue 4, Pages (November 2012)
Lysine 63 Polyubiquitination of the Nerve Growth Factor Receptor TrkA Directs Internalization and Signaling  Thangiah Geetha, Jianxiong Jiang, Marie W.
Volume 41, Issue 6, Pages (March 2011)
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Kai Li, Qiang Jiang, Xue Bai, Yi-Feng Yang, Mei-Yu Ruan, Shi-Qing Cai 
Christopher S. Brower, Konstantin I. Piatkov, Alexander Varshavsky 
Terunao Takahara, Tatsuya Maeda  Molecular Cell 
Kunio Nakatsukasa, Gregory Huyer, Susan Michaelis, Jeffrey L. Brodsky 
Volume 3, Issue 2, Pages (August 2002)
Susan K Lyman, Randy Schekman  Cell 
Volume 19, Issue 6, Pages (September 2005)
Volume 50, Issue 4, Pages (May 2013)
Volume 47, Issue 6, Pages (September 2012)
Volume 50, Issue 6, Pages (June 2013)
Volume 33, Issue 5, Pages (March 2009)
Volume 90, Issue 2, Pages (July 1997)
Volume 66, Issue 4, Pages e7 (May 2017)
Volume 70, Issue 3, Pages e6 (May 2018)
Volume 49, Issue 6, Pages (March 2013)
Impaired Trafficking of the Desmoplakins in Cultured Darier's Disease Keratinocytes  Jittima Dhitavat, Christian Cobbold, Natalie Leslie, Susan Burge,
Cytoskeletal Activation of a Checkpoint Kinase
Volume 3, Issue 2, Pages (August 2002)
USP15 Negatively Regulates Nrf2 through Deubiquitination of Keap1
Regulation of Yeast mRNA 3′ End Processing by Phosphorylation
Sebastian Rumpf, Stefan Jentsch  Molecular Cell 
Volume 6, Issue 2, Pages (August 2007)
Volume 27, Issue 6, Pages e4 (May 2019)
Cvt19 Is a Receptor for the Cytoplasm-to-Vacuole Targeting Pathway
Volume 107, Issue 5, Pages (November 2001)
Volume 26, Issue 12, Pages e4 (March 2019)
Volume 19, Issue 6, Pages (September 2005)
Yuki Okuda-Shimizu, Linda M. Hendershot  Molecular Cell 
Volume 36, Issue 4, Pages (November 2009)
Volume 65, Issue 5, Pages e4 (March 2017)
Unassembled Ig Heavy Chains Do Not Cycle from BiP In Vivo but Require Light Chains to Trigger Their Release  Marc Vanhove, Young-Kwang Usherwood, Linda.
The Engagement of Sec61p in the ER Dislocation Process
James H. Cormier, Taku Tamura, Johan C. Sunryd, Daniel N. Hebert 
Chih-Yung S. Lee, Tzu-Lan Yeh, Bridget T. Hughes, Peter J. Espenshade 
Misfolded Membrane Proteins Are Specifically Recognized by the Transmembrane Domain of the Hrd1p Ubiquitin Ligase  Brian K. Sato, Daniel Schulz, Phong.
Presentation transcript:

Volume 70, Issue 2, Pages 242-253.e6 (April 2018) Substrate Insolubility Dictates Hsp104-Dependent Endoplasmic-Reticulum-Associated Degradation  G. Michael Preston, Christopher J. Guerriero, Meredith B. Metzger, Susan Michaelis, Jeffrey L. Brodsky  Molecular Cell  Volume 70, Issue 2, Pages 242-253.e6 (April 2018) DOI: 10.1016/j.molcel.2018.03.016 Copyright © 2018 Elsevier Inc. Terms and Conditions

Molecular Cell 2018 70, 242-253.e6DOI: (10.1016/j.molcel.2018.03.016) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 1 The Metabolic Stabilities of Ste6 Truncations Are Variable (A) Schematic of the yeast 12-transmembrane a-factor transporter, Ste6, with the relative site of the Q1249 truncation (“Ste6∗”) marked by an arrowhead. (B) Metabolic stabilities were determined by cycloheximide chase analysis, and proteins were visualized by immunoblotting with an anti-hemagglutinin (HA) antibody; t1/2 indicates calculated half-life of each protein. (C) A bar graph depicting the relative half-lives of the Ste6 truncations. Data represent the means of n = 3 independent experiments, ±SEM. Molecular Cell 2018 70, 242-253.e6DOI: (10.1016/j.molcel.2018.03.016) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 2 The Metabolic Stabilities of Truncation Mutants in a Chimera Reflect the Half-Lives of the Analogous Ste6 Truncation Mutants (A) Schematic of the yeast dual pass transmembrane protein with the relative site of the Q394 truncation marked by an arrowhead. The chimera consists of the first transmembrane domain of Ste6 followed by a second poly Ala/Leu transmembrane domain annealed to NBD2 from Ste6. The full-length species (wild-type) and the Q394X protein were also recently referred to as “Chimera A” and “Chimera A∗” (Guerriero et al., 2017). (B) Metabolic stabilities were determined by cycloheximide chase analyses, and proteins were visualized by immunoblotting with an anti-HA antibody. Differences in stabilities between the Ste6 (Figure 1) and chimera (this figure) truncation series are likely due to expression level differences: Ste6 is expressed under the control of an endogenous promotor, but the proteins depicted in this figure are under the control of a higher expression (PGK) promoter. (C) A bar graph depicts the relative half-lives of the chimeras. Data represent the means of at least 3 independent experiments, ±SEM. Molecular Cell 2018 70, 242-253.e6DOI: (10.1016/j.molcel.2018.03.016) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 3 Protein Half-Life Correlates with Detergent Solubility (A) The cellular localization of the wild-type chimera, Q394X, and L385X was determined by indirect immunofluorescence microscopy. Proteins were detected with anti-HA antibody, anti-Kar2 antiserum was used to mark the ER, and the nucleus was visualized with DAPI. (B) Yeast strains lacking PDR5 and expressing either the wild-type chimera, Q394X, or L385X were treated with DMSO (closed circles) or 100 μM MG132 (open circles) for 30 min prior to a cycloheximide chase analysis performed at 26°C. Data represent the means of n = 9 (L385X) or n = 12 (wild-type chimera and Q394X) independent experiments, ±SEM; wild-type chimera, p < 0.001 for all time points; Q394X, p < 0.01 for all time points; L385X, p < 0.001 at the 30- and 60-min time points, for data ± MG132. (C) The metabolic stabilities of the truncation mutants were determined by cycloheximide chase analyses, and protein solubilities were determined after treatment with the non-ionic detergent, dodecyl-maltoside (DDM). Data represent the means of n = 4–6 independent experiments for stability measurements and n = 4 independent determinations for protein solubility. (D) Wild-type microsomes containing Q394X were treated with DDM or DDM in the presence of 6 M urea, and protein residence in the supernatant (S) and pellet (P) fractions was analyzed after centrifugation and immunoblotting. Sec61 was used as a control for membrane solubilization. Molecular Cell 2018 70, 242-253.e6DOI: (10.1016/j.molcel.2018.03.016) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 4 The ERAD of an Unstable, Aggregation-Prone Substrate Is Hsp104 Dependent The stabilities of Q394X in the indicated wild-type and mutant strains were determined by cycloheximide chase analyses at 37°C. (A) The yeast cytosolic Hsp110, Sse1; n = 3 independent experiments, ±SEM. (B) The yeast cytosolic disaggregase, Hsp104; n = 3–6 independent experiments, ±SEM; black asterisks apply to the HSP104 versus hsp104Δ comparison, and the red asterisk applies to the HSP104 versus HSP104 OE comparison. In all panels, ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001. Molecular Cell 2018 70, 242-253.e6DOI: (10.1016/j.molcel.2018.03.016) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 5 Hsp104-GFP Forms ER Puncta in Yeast Expressing an Aggregation-Prone Membrane Protein HSP104-GFP pdr5Δ and HSP104-GFP pdr5Δ mCherry-Scs2-tm yeast containing either an empty vector (EV) or a Q394X expression vector were incubated at 37°C for 1 hr. (A) HSP104-GFP pdr5Δ cells containing either an EV or the Q394X expression vector were treated with DMSO or MG132. Data to the right represent the averages of at least 500 cells from at least 3 independent transformations. (B) HSP104-GFP pdr5Δ cells expressing the integrated mCherry-Scs2-tm ER marker and containing either an EV or the Q394X expression vector were treated with MG132. Based on analysis of >590 cells obtained from at least 2 independent transformations, the percentage of cells with punctae in the presence of the vector control was 3% (18/590), and when containing the expression vector, the percentage was 31% (380/1,244). Molecular Cell 2018 70, 242-253.e6DOI: (10.1016/j.molcel.2018.03.016) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 6 Hsp104 Disaggregates Ubiquitinated Q394X (A) A schematic of the flotation assay used to measure substrate oligomerization. Cell lysates from HSP104 or hsp104Δ strains expressing the Q394X mutant incubated at 37°C for 1.5 hr were prepared and analyzed by equilibrium sucrose density centrifugation. (B and C) Proteins in each fraction were TCA precipitated and immunoblotted with anti-HA antibody to detect (B) Q394X or (C) were denatured and immunoprecipitated to detect ubiquitinated Q394X. For (C), compare the boxed regions in lanes 6 and 7 from wild-type and hsp104Δ cells, as well as the quantification to the right. (D) The migration of Sec61 was used to mark the ER. Data represent the means of n = 4–5 independent experiments, ±SEM; ∗p < 0.05. Molecular Cell 2018 70, 242-253.e6DOI: (10.1016/j.molcel.2018.03.016) Copyright © 2018 Elsevier Inc. Terms and Conditions

Figure 7 Hsp104 Acts prior to Substrate Retrotranslocation (A) A schematic of the in vitro ubiquitination/retrotranslocation assay. (B) Ubiquitinated Q394X was immunoprecipitated from the retrotranslocated supernatant (S) fractions and the membrane-bound pellet (P) fractions after immunoprecipitation. Reactions were run in the presence of either wild-type (HSP104) or hsp104Δ cytosol and in the presence or absence of ATP, as indicated. The native molecular weight (arrow) and high-molecular-weight species (asterisk) of Q394X are marked. (C) The in vitro assay was scaled up 8-fold with cytosol purified from BY4742 wild-type yeast and ER-enriched microsomes purified from BY4742 yeast containing either an empty vector (E) or the Q394X expression vector (Q). The substrate was immunoprecipitated from the pellet (membrane) or supernatant (cytosol, retrotranslocated) fractions, and the indicated components were subsequently examined by immunoblot. (D) The membrane-bound (P) fraction in a ubiquitination/retrotranslocation assay was collected and washed in 6 M urea to differentiate between membrane-integrated (P) and retrotranslocated, membrane-associated Q394X (urea supernatant [US]). (E) ER-enriched microsomes were washed with 6 M urea and collected by centrifugation. Samples were also either diluted in buffer or incubated in the presence of SDS. The solubilized fractions (S) and the resuspended pelleted fractions (P) were TCA precipitated and resolved by SDS-PAGE. Blots were incubated with antibodies against the HA tag in Q394X; the ER resident integral membrane protein, Sec61; and the ER-associated cytosolic proteins, Cdc48 and Hsp104. (F) The stability of Q394X was determined in mutant cdc48-2 yeast containing either an EV or a vector to overexpress Hsp104 (OE104). Cultures were shifted to 39°C for 2.5 hr and chased for 1 hr at 39°C. n = 3 independent experiments, ±SEM. ∗∗p < 0.01; ∗∗∗p < 0.001. Molecular Cell 2018 70, 242-253.e6DOI: (10.1016/j.molcel.2018.03.016) Copyright © 2018 Elsevier Inc. Terms and Conditions